Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Sara Shalin to Sebaceous Gland Neoplasms

This is a "connection" page, showing publications Sara Shalin has written about Sebaceous Gland Neoplasms.

 
Connection Strength
 
 
 
1.949
 
  1. Hamza MA, Quick CM, Williams HR, Patil NM, Shalin SC. HPV-associated Vulvar Intraepithelial Carcinoma With Sebaceous Differentiation: Report of 2 Cases. Int J Gynecol Pathol. 2023 Jul 01; 42(4):338-346.
    View in: PubMed
    Score: 0.882
  2. Shalin SC, Sakharpe A, Lyle S, Lev D, Calonje E, Lazar AJ. p53 staining correlates with tumor type and location in sebaceous neoplasms. Am J Dermatopathol. 2012 Apr; 34(2):129-35; quiz 136-8.
    View in: PubMed
    Score: 0.423
  3. Shalin SC, Lyle S, Calonje E, Lazar AJ. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications. Histopathology. 2010 Jan; 56(1):133-47.
    View in: PubMed
    Score: 0.362
  4. Clark LN, Elwood HR, Uhlenhake EE, Smoller BR, Shalin SC, Gardner JM. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a highly sensitive marker of sebaceous differentiation in normal and neoplastic sebocytes. J Cutan Pathol. 2016 Aug; 43(8):657-62.
    View in: PubMed
    Score: 0.141
  5. Uhlenhake EE, Clark LN, Smoller BR, Shalin SC, Gardner JM. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear cell neoplasms. J Cutan Pathol. 2016 Aug; 43(8):649-56.
    View in: PubMed
    Score: 0.141
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.